Evidence map›Paper›PMID 42576606›Full record

ArticleeLife2026

In vivo mapping of striatal neurodegeneration in Huntington's disease with Soma and Neurite Density Imaging.

Vasileios Ioakeimidis, Marco Palombo, Chiara Casella, Lucy Layland, Carolyn McNabb, Robin Schubert, Philip Pallmann, Monica Busse, Cheney Drew, Sundus Alusi and 4 more

Abstract read
In one paragraph

Article in eLife, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Vasileios IoakeimidisCardiff University Brain Research Imaging Centre (CUBRIC), School of Psychology, Cardiff University, Cardiff, United Kingdom.ORCID https://orcid.org/0000-0002-4117-0781
Marco PalomboCardiff University Brain Research Imaging Centre (CUBRIC), School of Psychology, Cardiff University, Cardiff, United Kingdom.
Chiara CasellaEarly Life Imaging Research Department, School of Biomedical Engineering and Imaging Sciences, King's College London, London, United Kingdom.ORCID https://orcid.org/0000-0002-0292-3330
Lucy LaylandCardiff University Brain Research Imaging Centre (CUBRIC), School of Psychology, Cardiff University, Cardiff, United Kingdom.
Carolyn McNabbCardiff University Brain Research Imaging Centre (CUBRIC), School of Psychology, Cardiff University, Cardiff, United Kingdom.ORCID https://orcid.org/0000-0002-6434-5177
Robin SchubertGeorge Huntington Institut (GHI), Muenster, Germany.
Philip PallmannCentre for Trials Research, School of Medicine, Cardiff University, Cardiff, United Kingdom.ORCID https://orcid.org/0000-0001-8274-9696
Monica BusseCentre for Trials Research, School of Medicine, Cardiff University, Cardiff, United Kingdom.ORCID https://orcid.org/0000-0002-5331-5909
Cheney DrewCentre for Trials Research, School of Medicine, Cardiff University, Cardiff, United Kingdom.
Sundus AlusiThe Walton Centre for Neurology and Neurosurgery, Fazakerley, Liverpool, United Kingdom.
Timothy HarrowerRoyal Devon and Exeter NHS Trust, Exeter, United Kingdom.ORCID https://orcid.org/0000-0002-2558-9726
Jane DaviesCardiff and Vale University Health Board, Main University Hospital Wales Building, Cardiff University, Health Park Campus, Cardiff, United Kingdom.ORCID https://orcid.org/0000-0002-9409-8605
Anne RosserCardiff University Brain Repair Group, School of Biosciences, Cardiff University, Cardiff, United Kingdom.
Claudia Metzler-BaddeleyCardiff University Brain Research Imaging Centre (CUBRIC), School of Psychology, Cardiff University, Cardiff, United Kingdom.ORCID https://orcid.org/0000-0002-8646-1144

Funding

HCRW_ NIHR-FS(A)-2022UKRI MR/T020296/2Wellcome TrustWellcome Trust 10.35802/104943Wellcome Trust 10.35802/204005
6 · The paper itself

Abstract

Huntington's disease (HD) is an inherited neurodegenerative disorder characterised by progressive cognitive and motor decline driven by basal ganglia (BG) atrophy. Clinical trials of novel disease-modifying therapies are ongoing, creating a need for sensitive non-invasive imaging biomarkers. Soma and Neurite Density Imaging (SANDI) is a multi-shell diffusion MRI model that estimates intracellular signal fractions from sphere-shaped soma and shows promise as a marker of neurodegeneration. The objectives of this study were to characterise HD-related microstructural abnormalities in the BG using SANDI and to examine relationships between SANDI and volumetric measurements and motor performance. T1- and diffusion-weighted images (

Indexed as

Corpus StriatumHuntington DiseaseNeuritesAdultAgedBasal GangliaDiffusion Magnetic Resonance ImagingFemaleHumansMaleMiddle Agedbasal gangliabrain microstructurehumanHuntington's diseasemotor functionneurodegenerationneuroscienceSANDI

Identifiers

PMID42576606
PMCPMC13461150

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.